… of pertinent scientific literature evaluating the interaction … drug interaction liability is presented.
This review also highlights the regulatory science viewpoint on botanical–drug interactions …

… for drug-drug interactions. The chapters in this book present a comprehensive review of the
scientific and regulatory aspects of drug-drug interactions … The topics covered include drug …

… a regulatory viewpoint on transporters and their potential role in drug–drug interactions. It first
… transporters has increased dramatically over the years because of the scientific progress in …

… hampered by unknown factors to be discovered as science evolves and as the knowledge
of the drug accumulates. Therefore, the ability to quantitatively predict the magnitude of in vivo …

… Such data are useful in the prediction of pharmacokinetic drug-drug interactions and
interpatient variability in drug exposure. The science underlying P450 reaction phenotyping has …

… ones, the common points and differences among the US, Europe (EU) and Japan are
discussed and shared from the viewpoint of scientific evaluation and international harmonization. …

… In this Viewpoint article, I discuss some of these obstacles, and suggest strategies by which
… However, the scientists who study the issue are unlikely to alter how they disseminate their …

… Drug-drug interactions (DDI) are key aspects of drug metabolism and pharmacokinetic
considerations and are studied in both preclinical development and throughout the clinical …

… analyzing data from a drug interaction study. … drug-drug interactions may help in a better
management of pharmacotherapy including the avoidance of clinically relevant drug interactions…

… scientists have exploited the computerized modeling methods in different‏ aspects of
pharmaceutical sciences including drug … and personalized medicine viewpoints, effective standard …